Cited 0 time in
Short Caco-2 model for evaluation of drug permeability: A sodium valerate-assisted approach
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Rehman, Naveed Ur | - |
| dc.contributor.author | Shin, Seong-Ah | - |
| dc.contributor.author | Lee, Chang Sup | - |
| dc.contributor.author | Song, Miyoung | - |
| dc.contributor.author | Kim, Hyun Joon | - |
| dc.contributor.author | Chung, Hye Jin | - |
| dc.date.accessioned | 2024-07-17T09:00:14Z | - |
| dc.date.available | 2024-07-17T09:00:14Z | - |
| dc.date.issued | 2024-08 | - |
| dc.identifier.issn | 0378-5173 | - |
| dc.identifier.issn | 1873-3476 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/71261 | - |
| dc.description.abstract | The human colorectal adenocarcinoma cell line Caco-2, widely used for studying intestinal drug permeability, is typically grown on permeable filter supports and matures in 21 days with frequent media changes. The process is labor-intensive, prone to contamination, and has low throughput, contributing to the overall high utilization cost. Efforts to establish a low-cost, high-throughput, and short-duration model have encountered obstacles, such as weaker tight junctions causing monolayer leaks, incomplete differentiation resulting in low transporter expression, intricate and challenging protocols, and cytotoxicity, limiting the usability. Hence, this study aimed to develop a low-cost, efficient, and short-duration model by addressing the aforementioned concerns by customizing the media and finding a safe differentiation inducer. We generated a new rapid model using sodium valerate, which demonstrated sufficient transporter activity, improved monolayer integrity, and higher levels of differentiation markers than the 21-day model. Furthermore, this model exhibited consistent and reliable results when used to evaluate drug permeability over multiple days of repeated use. This study demonstrates the potential of a sodium valerate-assisted abbreviated model for drug permeability assessment with economic and practical advantages. © 2024 Elsevier B.V. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Short Caco-2 model for evaluation of drug permeability: A sodium valerate-assisted approach | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.ijpharm.2024.124415 | - |
| dc.identifier.scopusid | 2-s2.0-85198123139 | - |
| dc.identifier.wosid | 001269382800001 | - |
| dc.identifier.bibliographicCitation | International Journal of Pharmaceutics, v.661 | - |
| dc.citation.title | International Journal of Pharmaceutics | - |
| dc.citation.volume | 661 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | IN-VITRO | - |
| dc.subject.keywordPlus | CELL-CULTURE | - |
| dc.subject.keywordPlus | ORAL ABSORPTION | - |
| dc.subject.keywordPlus | SCREENING MODEL | - |
| dc.subject.keywordPlus | BARRIER MODEL | - |
| dc.subject.keywordPlus | DIFFERENTIATION | - |
| dc.subject.keywordPlus | LINE | - |
| dc.subject.keywordPlus | BIOAVAILABILITY | - |
| dc.subject.keywordPlus | APOPTOSIS | - |
| dc.subject.keywordPlus | BUTYRATE | - |
| dc.subject.keywordAuthor | Caco-2 cell | - |
| dc.subject.keywordAuthor | Differentiation | - |
| dc.subject.keywordAuthor | Permeability | - |
| dc.subject.keywordAuthor | Sodium valerate | - |
| dc.subject.keywordAuthor | Tight junction | - |
| dc.subject.keywordAuthor | Transporter | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
